Issue Brief: Access to Prescription Digital Therapeutics Act

AMCP Urges Passage of the Access to Prescription Digital Therapeutics Act of 2023 

AMCP supports the Access to Prescription Digital Therapeutics Act of 2023. Expanding coverage of PDTs will improve care for millions of American patients and help standardize reimbursement practices and coding of these therapies across both public and private payers. This bill will help ensure that the greatest number of patients possible are receiving innovative, modern care, which is especially vital for closing care gaps caused by specialist shortages or geographic obstacles. As private payers continue to expand coverage, lack of a comprehensive benefit category is creating a disparity of access for Medicare and Medicaid beneficiaries. AMCP urges Members of Congress to cosponsor and ultimately enact the Access to Prescription Digital Therapeutics Act of 2023 (S. 723/H.R. 1458) to authorize stable, comprehensive coverage under Medicare and Medicaid, thereby increasing patient access and quality of care.

Download Issue Brief

Related